Synthesis and Evaluation of Novel Anticancer and Anti-Inflammatory Agents
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Pharmaceutical Science".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 2989
Special Issue Editors
Interests: pharmacology; drug discovery; cancer biology; inflammation immunology
Interests: natural product chemistry; liquid chromatography; mass spectrometry; new drugs’ development
Interests: cancer physiology; immunopharmacology; translational medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The ongoing global burden of cancer and inflammatory diseases underscores the urgent need for novel therapeutic strategies. This Special Issue on the “Synthesis and Evaluation of Novel Anticancer and Anti-inflammatory Agents” aims to gather cutting-edge research focused on the design, synthesis, and biological evaluation of new anticancer and anti-inflammatory agents. We invite contributions that explore innovative approaches to drug discovery, including the development of small molecules, peptides, and other bioactive compounds with potential therapeutic applications. This Special Issue is particularly interested in studies that not only focus on synthetic methodologies but also emphasize the mechanisms of action, pharmacokinetics, and structure–activity relationships of these novel agents. Submissions that incorporate interdisciplinary approaches, combining medicinal chemistry, molecular biology, and pharmacology, are highly encouraged. By bringing together a diverse range of expertise, this Special Issue seeks to contribute to the advancement of effective treatments for cancer and inflammatory diseases, ultimately improving patient outcomes. We welcome original research articles, comprehensive reviews, and insightful perspectives that will enrich the understanding of these critical areas in drug development.
Dr. Po-Jen Chen
Dr. Yu-Chia Chang
Dr. Shun-Hua Chen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anticancer agents
- anti-inflammatory agents
- pharmacology
- molecular and cell biology
- drug design
- medicinal chemistry
- pharmacodynamics
- pharmacokinetics
- structure–activity relationship (SAR)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.